Systemic scleroderma associated to a glomerulonephritis with anti-MPO antibodies: A case report and literature review;Sclérodermie systémique associée à une glomérulonéphrite avec ANCA anti-MPO positifs: À propos d'un cas et revue de la littérature

Revue Medicale de Bruxelles

Volumn 29, Issue 6, 2008, Pages 559-567

  Bakoto Sol, E ^a   Bonkain, F ^a   Vande Houtte, K ^a   Dratwa, M ^a  

^a BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

Author keywords

D penicillamine; Extracapillary glomerulonephritis; Scleroderma

Indexed keywords

GLOMERULUS BASEMENT MEMBRANE ANTIBODY; IMMUNOSUPPRESSIVE AGENT; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PENICILLAMINE;

ACUTE KIDNEY FAILURE; AGED; ANAMNESIS; ANCA ASSOCIATED VASCULITIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; GLOMERULONEPHRITIS; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; PLASMAPHERESIS; SYSTEMIC SCLEROSIS;

AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CREATININE; FEMALE; GLOMERULONEPHRITIS; HUMANS; KIDNEY FAILURE, ACUTE; KIDNEY GLOMERULUS; LEUKOCYTE COUNT; PLATELET COUNT; SCLERODERMA, SYSTEMIC; VASCULITIS;

EID: 58149343986     PISSN: 00353639     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Steen VD, Medsger TA Jr : Long-term outcomes of scleroderma renal crisis. Ann Intern Med 2000 ; 133 : 600-3
2. Uetrecht J : Role of animal models in the study of drug-induced hypersensitivity reactions. AAPS J 2006 ; 13 : 7 : E914-21
3. Qasim FJ, Thiru S, Gillespie K : Gold and D-penicillamine induce vasculitis and up-regulate mRNA for IL-4 in the Brown Norway rat : support for a role for Th2 cell activity. Clin Exp Immunol 1997 ; 108 : 438-45
4. Karpinsky J, Jothy S, Radoux V, Levy M, Baran D : D-penicillamine-induced crescentic glomerulonephritis and antimyeloperoxidase antibodies in a patient with scleroderma : case report and review of the literature. Am J Nephro 1997 ; 17 : 528-32
5. Marchand-Courville S, Dhib M, Fillastre JP, Godin M : Extracapillary glomerulonephritis secondary to D-penicillamine. A propos of one case and review of the literature. Nephrologie 1998 ; 19 : 25-32
6. Ntoso KA, Tomaszewski JE, Jimenez SA, Neilson EG : Penicillamine-induced rapidly progressive glomerulonephritis in patients with progressive systemic sclerosis : successful treatment of two patients and a review of the literature. Am J Kidney Dis 1986 ; 8 : 159-63
7. Devogelaer JP, Pirson Y, Vandenbroucke JM, Cosyns JP, Brichard S, Nagant de Deuxchaisnes C : D-penicillamine induced crescentic glomerulonephritis : report and review of literature. J Rheumatol 1987 ; 14 : 1036-41
8. Endo H, Hosono T, Kondo H : Antineutrophiles cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis. J Rheumatol 1994 ; 21 : 864-70
9. Cheung G, Chew G, Wyndham R, Peters M, Riminton S : Myeloperoxidase- antineutrophil cytoplasmic antibody seroconversion and fulminant vascultis in scl-70 positive scleroderma. Intern Med J 2007 ; 37 : 205-7
10. Naniwa T, Banno S, Sugiura Y et al. : Pulmonary-renal syndrome in systemic sclerosis : a report of three cases and review of the litterature. Mod Rheumatol 2007 ; 17 : 37-44, Epub 2007
11. Lee AT, Burnet S : Corticosteroid-induced scleroderma renal crisis. Med J Aust 2002 ; 177 : 459
12. Hillis GS, Khan IH, Simpson JG, Rees AJ : Scleroderma, D-Penicillamine treatment, and progressive renal failure associated with positive antimyeloperoxydase antineutrophil cytoplasmic antibodies. Am J Kidney Dis 1997 ; 30 : 279-81
13. Grypiotis P, Cozzi F, Ruffatti A : Autoantibodies to bactericidal/ permeability-increasing protein and cathepsin G in systemic sclerosis. J Rheumatol 2004 ; 31 : 1468-9
14. Caramaschi P, Biasi D, Tonolli E, Carletto A, Bambara LM : Antineutrophil cytoplasmic antibodies in scleroderma patients : first report of a case with anti-proteinase 3 antibodies and review of the literature. Revue du Rhumatisme 2002 ; 69 : 265-9
15. Yang JJ, Jennette JC, Falk RJ : Immune complex glomerulonephritis is induced in rats immunized with heterologous myeloperoxidase. Clin Exp Immunol 1994 ; 97 : 466-73
16. D'Agati V : Antineutrophil cytoplasmic antibody and vasculitis : much more than a disease marker. J Clin Invest 2002 ; 110 : 919-21
17. Belmont HM : Treatment of ANCA-associated systemic vasculitis. Bull NYU Hosp Jt Dis 2006 ; 64 : 60-6
18. Morgan MD, Harper L, Williams J, Savage C : Antineutrophil cytoplasmic antibody-associated glomerulonephritis. J Am Soc Nephrol 2006 ; 17 : 1224-34. Epub 2006
19. Jayne DR, Gaskin G, Rasmussen N et al. : European Vasculitis Study Group : Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 2007 ; 18 : 2180-8. Epub 2007
20. Jayne D, Rasmussen N, Andrassy K et al. ; European Vasculitis Study Group : A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003 ; 349 : 36-44
21. Rihova Z, Jancova E, Merta M et al. : Long-term outcome of patients with antineutrophil cytoplasmic autoantibody-associated vasculitis with renal involvement. Kidney Blood Press Res 2005 ; 28 : 144-52. Epub 2005
22. de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R et al. : Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis : A prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol 2006 ; 17 : 2264-74. Epub 2006
23. Clements PJ , Seibold JR, Furst DE et al. : High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial : lessons learned. Seminars Arthritis Rheumatism 2004 ; 33 : 249-63
24. Alvarez Vega JL, Salazar Vallinas JM, Ortega Alberdi R : Pulmonary haemorrhage and focal necrotizing glomerulonephritis in a case of systemic sclerosis. Clin Rheumatol 1992 ; 11 : 116-9
25. Huong DL, Papo T, Gatfosse M, Frances C, Godeau P, Beaufils H : Antineutrophil cytoplasmic autotoantibodies in systemic sclerosis with renal failure. J Rheumatol 1995 ; 22 : 791-2
26. Akimoto S, Ishikawa O, Tamura T, Miyachi Y : Antineutrophil cytoplasmic autoantibodies in patients with systemic sclerosis. Br J Dermatol 1996 ; 134 : 407-10
27. Omote A, Muramatsu M, Sugimoto Y et al. : MPO-ANCA-related scleroderma renal crisis treated with double filtration-plamapheresis. Int Med 1997 ; 36 : 508-13
28. Carvajal C, Bemis P, Sanz A, Garcia A, Garcia-Vadillo, Traver JA : Antineutrophil cytoplasmic autoantibodies (ANCA) and systemic sclerosis. Nephrol Dial Transplant 1997 ; 12 : 576-7
29. Locke IC, Worrall JG, Leaker B, Black CM, Cambridge G : Autoantibodies to myeloperoxidase in systemic sclerosis. J Rheumatol 1997 ; 24 : 86-9
30. Anders HJ, Wiebecke B, Haedecke C, Sanden S, Combe C, Schlondorff D : MPO-ANCA -Positive crescentic glomerulonephritis : a distinct entity of scleroderma renal disease ? Am J Kidney Dis 1999 ; 33 : e3
31. Katrib A, Strugess A, Bertouch JV : Systemic sclerosis and antineutrophil cytoplasmic autoantibody-associated renal failure. Rheumatol Int 1999 ; 19 : 61-3
32. Kyndt X, Ducq P, Bridoux F, Reumaux D, Makdassi R : Extracapillary glomerulonephritis with anti-myeloperoxidase antibodies in 2 patients with systemic scleroderma treated with penicillamine D. Presse Med 1999 ; 28 : 67-70
33. Villaverde V, Balsa A, Cabezas JA, Fernández-Prada M, Torre A, Mola EM : Normotensive renal failure in a patient with systemic sclerosis and p-antineutrophil cytoplasmic autoantibodies which developed into Paget's disease of bone after immunosuppressive therapy. Rheumatology (Oxford) 1999 ; 38 : 190-1
34. Garcia-Porrua C, Gonzalez-Gay MA, Bouza P : D-penicillamine induced crescentic glomerulonephritis in a patient with scleroderma. Nephron 2000 ; 84 : 101-2
35. Yamashita K, Yorioka N, Kyuden Y, Naito T : A case of CREST syndrome and myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis. Clin Nephrol 2000 ; 53 : 296-300
36. Maes B, Van Mieghem A, Messiaen T, Kuypers D, Van Damme B, Vanrenterghem Y : Limited cutaneous systemic sclerosis associated with MPO-ANCA positive renal small vessel vasculitis of the microscopic polyangiitis type. Am J Kidney Dis 2000 ; 36 : E16
37. Derek CT, Jimenez SA : Goodpasture-like syndrome induced by Dpenicillamine in a patient with systemic sclerosis : report and review of literature. J Rheumatol 2003 ; 30 : 1616-20
38. Tomioka M, Hinoshita F, Miyauchi N, Akiyama Y, Saima S, Hiroe M : ANCA-related crescentic glomerulonephritis in a patient with scleroderma without marked dermatological change and malignant hypertension. Intern Med 2004 ; 43 : 496-502
39. Steen VD, Syzd A, Johnson JP, Greenberg A, Medsger TA Jr : Kidney disease other than renal crisis in patients with diffuse scleroderma. J Rheumatol 2005 ; 32 : 649-55
40. Kamen DL, Wigley FM, Brown AN : Antineutrophil Cytoplasmic Antibody-Positive Crescentic Glomerulonephritis in Scleroderma. A Different Kind of Renal Crisis J Rheumatol 2006 ; 33 : 1886-8
41. Arnaud L, Huart A, Plaisier E et al. : ANCA-related crescentic glomerulonephritis in systemic sclerosis : revisiting the «normotensive scleroderma renal crisis». Clin Nephrol 2007 ; 68 : 165-70